Translabyrinthine surgery for disabling vertigo in vestibular schwannoma patients

Godefroy, Willem P.; Hastan, Deniz; Mey, Andel G. L. van der

doi:10.1111/j.1365-2273.2007.01427.x

Cited by 51 publications

(65 citation statements)

References 22 publications

(44 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[56][57][58][59][60][61][62][63][64][65][66][67][68] Forty seven unique trials were included in the review. 4,[34][35][36][37][38][39][40] No systematic reviews or randomised prospective studies were found measuring QoL in VS. Of the 47 trials, nine were prospective studies and underwent formal data extraction. The remaining trials reported retrospective cross-sectional designs.…”

Section: Resultsmentioning

confidence: 99%

“…77 Eight studies met the inclusion criteria outlined above and were included. 4,[34][35][36][37][38][39][40] The study details are summarised in Table 1.…”

Section: Resultsmentioning

confidence: 99%

“…4,[34][35][36][37][38][39][40] The assessment of QoL has mostly been made using generic widely known assessment tools such as the Short Form Questionnaire (SF-36) 41,42 and the Glasgow Benefit Inventory (GBI). 43 However, this evidence is of varying quality.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Systematic review of quality of life in the management of vestibular schwannoma

Gauden¹,

Weir²,

Hawthorne³

et al. 2011

Journal of Clinical Neuroscience

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

“…77 Eight studies met the inclusion criteria outlined above and were included. 4,[34][35][36][37][38][39][40] The study details are summarised in Table 1.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Systematic review of quality of life in the management of vestibular schwannoma

Gauden¹,

Weir²,

Hawthorne³

et al. 2011

Journal of Clinical Neuroscience

View full text Add to dashboard Cite

“…18,23 It is interesting that the microsurgery cohort scored poorer in the PANQOL balance subdomain since it is commonly held that tumor resection is advantageous for treatment of patients who are experiencing debilitating vertigo. 10 This seemingly paradoxical observation can be explained by the differences in dizzy symptoms patients experience following microsurgery, SRS, and observation as well as treatment selection bias. Microsurgery nearly always imparts a complete ipsilateral peripheral vestibular paresis, often resulting in acute postoperative vertigo; however, over a period of several weeks or months most subjects achieve central compensation with a significant improvement in symptoms.…”

Section: Discussionmentioning

confidence: 99%

Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls

Carlson¹,

Tveiten²,

Driscoll

et al. 2015

JNS

183

178

View full text Add to dashboard Cite

abbreviatioNs AAO-HNS = American Academy of Otolaryngology-Head and Neck Surgery; CPA = cerebellopontine angle; GBI = Glasgow Benefit Inventory; HRQOL = health-related quality of life; IQR = interquartile range; MCID = minimum clinically important difference; PANQOL = Penn Acoustic Neuroma Quality-of-Life; PROMIS-10 = 10-item Patient-Reported Outcomes Measurement Information System; SF-36 = 36-Item Short Form Health Survey; SRS = stereotactic radiosurgery; VS = vestibular schwannoma. submitted March 18, 2014. accepted November 11, 2014. iNclude wheN citiNg Published online January 2, 2015; DOI: 10.3171/2014.11.JNS14594. disclosure The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Internal departmental funding was used without commercial sponsorship or support. obJect The optimal treatment for sporadic vestibular schwannoma (VS) is highly controversial. To date, the majority of studies comparing treatment modalities have focused on a narrow scope of technical outcomes including facial function, hearing status, and tumor control. Very few publications have investigated health-related quality of life (HRQOL) differences between individual treatment groups, and none have used a disease-specific HRQOL instrument. methods All patients with sporadic small- to medium-sized VSs who underwent primary microsurgery, stereotactic radiosurgery (SRS), or observation between 1998 and 2008 were identified. Subjects were surveyed via postal questionnaire using the 36-Item Short Form Health Survey (SF-36), the 10-item Patient-Reported Outcomes Measurement Information System short form (PROMIS-10), the Glasgow Benefit Inventory (GBI), and the Penn Acoustic Neuroma Quality-of-Life (PANQOL) scale. Additionally, a pool of general population adults was surveyed, providing a nontumor control group for comparison. results A total of 642 respondents were analyzed. The overall response rate for patients with VS was 79%, and the mean time interval between treatment and survey was 7.7 years. Using multivariate regression, there were no statistically significant differences between management groups with respect to the PROMIS-10 physical or mental health dimensions, the SF-36 Physical or Mental Component Summary scores, or the PANQOL general, anxiety, hearing, or energy subdomains. Patients who underwent SRS or observation reported a better total PANQOL score and higher PANQOL facial, balance, and pain subdomain scores than the microsurgical cohort (p < 0.02). The differences in scores between the nontumor control group and patients with VS were greater than differences observed between individual treatment groups for the majority of measures. coNclusioNs The differences in HRQOL outcomes following SRS, observation, and microsurgery for VS are small. Notably, the diagnosis of VS rather than treatment strategy most significantly impacts quality of life. Understanding that a large number of VSs do not grow following discovery, and that intervention does not...

show abstract

“…In this specific group of patients, translabyrinthine tumor removal significantly improved the patients' quality of life. 20 In their prospective study, these authors found a significant improvement of Dizziness Handicap Inventory (DHI) total scores and Short Form-36 scales on physical and social functioning, role-physical functioning, role-emotional functioning, mental health and general health at 12 months after surgery when compared with preoperative scores. The size of an inferior vestibular nerve (IVN) and vestibular schwannoma (VS) correlated with computerized dynamic platform posturography findings, suggest that the nerve branch of origin of a VS appears to influence the nature of vestibular adaptation mechanisms in untreated VS tumors.…”

Section: Balance and Vestibular Functionmentioning

confidence: 99%

Management of Vestibular Schwannoma: Dependence on Stakeholder's View for Small and Medium-Sized Tumors

Gouveris¹,

Zisiopoulou²,

Mann³

2011

An International Journal of Otorhinolaryngology Clinics

View full text Add to dashboard Cite

Management options for patients with vestibular schwannoma include observation and active treatment, namely surgical resection, gamma knife stereotactic radiosurgery or fractionated radiation therapy. Although for large tumors microsurgery remains the mainstay of treatment, management of the small-and medium-sized vestibular schwannomas has been the matter of considerable controversy. Computerized clinical decision support systems have been developed to assist clinicians in this demanding task. Nonetheless, the complexity of the problem requires adaptation of the decision strategy to specific circumstances arising within a particular clinical scenario which can not always be modeled with adequate precision or addressed adequately within a mathematical framework. We present a set of clinical, neurophysiologic and radiologic parameters and the respective evidence which may guide carers' decisions. These parameters include the size, growth rate and localization of the tumor, the age, general medical condition, facial nerve function, hearing and hearing deterioration rate, balance, vestibular and trigeminal nerve function of the affected individual, the estimated risk of malignant transformation and radiation-induced tumors, the health-related quality of life measures, the patient's and surgeon's preference and the issue of cost-effectiveness. A complex decision analysis, guided by evidence and tailored to each individual patient is required.

show abstract

Translabyrinthine surgery for disabling vertigo in vestibular schwannoma patients

Cited by 51 publications

References 22 publications

Systematic review of quality of life in the management of vestibular schwannoma

Systematic review of quality of life in the management of vestibular schwannoma

Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls

Management of Vestibular Schwannoma: Dependence on Stakeholder's View for Small and Medium-Sized Tumors

Contact Info

Product

Resources

About